Biofrontera vs Pelthos Therapeutics
BFRI and PTHS side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BFRI and PTHS compare
Pelthos Therapeutics is the larger company, worth 3.2 times as much as Biofrontera ($27.4M against $8.5M).
Biofrontera keeps more of each dollar of sales as profit, with a net margin of −13.8% compared with −200% at Pelthos Therapeutics.
Biofrontera scores higher on the StockData Score (10 against 2 for Pelthos Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BFRI | PTHS |
|---|---|---|
| Size and price | ||
| Market cap | $8.5M | $27.4M |
| Share price | $0.570 | $7.15 |
| Change, 1 year | −36.0% | −79.4% |
| Change, 5 years | −99.6% | – |
| Beta (5Y) | 1.96 | 0.91 |
| Employees | 92 | 92 |
| StockData Score | ||
| Total score | 10 (better) | 2 |
| Valuation score | 1 | 1 |
| Growth score | 2 (better) | 0 |
| Performance score | 2 (better) | 0 |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.2× (better) | 0.6× |
| P/B | 1.4× | – |
| FCF yield | −93.7% | – |
| Growth | ||
| Revenue growth (TTM) | 17.8% | – |
| Revenue growth, 5Y average | 17.2% | – |
| Profitability | ||
| Gross margin | – | 78.6% |
| Operating margin | −14.2% (better) | −133% |
| Net margin | −13.8% (better) | −200% |
| FCF margin | −17.2% | – |
| Return on equity | −988% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −7.8× |
| Current ratio | 1.18 | 1.98 (better) |
| Altman Z-score | −6.36 | −1.83 (better) |
| Piotroski F-score | 3 | 5 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 18.6% | 35.6% |
| Held by insiders | 23.6% | – |
| Insider net buying, 12 months | – | $794K |
| Short interest, % of float | 1.7% | – |
Go deeper
- BFRI stock overview
- BFRI income statement
- BFRI valuation and score
- PTHS stock overview
- PTHS income statement
- PTHS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.